Medical Condition News

RSS

First study to examine relationship of risky content in alcohol ads to youth exposure

The content of alcohol ads placed in magazines is more likely to be in violation of industry guidelines if the ad appears in a magazine with sizable youth readership, according to a new study from the Center on Alcohol Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg School of Public Health. Published in the Journal of Adolescent Health, the study is the first to measure the relationship of problematic content to youth exposure, and the first to examine risky behaviors depicted in alcohol advertising in the past decade.

9 Aug 2012

Viewpoints: Dubious ad on Romney's role in cancer death; British health plan has problems of its own

He sits at a kitchen table, nursing a cup of coffee, talking about what happened after Bain Capital closed down his steel plant in 2001. He lost his job; his family lost its health insurance. His wife felt lousy but didn't go to the doctor, to spare the family worry and expense. When she finally ended up in the hospital, the diagnosis was cancer. She had 22 days to live.

9 Aug 2012

MedPage Today, CollabRx sign license agreement for Oncology Next

Tegal Corporation today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietary Therapy Finder tool to MedPage Today, Everyday Health, Inc.'s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.

9 Aug 2012

The ALS Association announces new grants to support research on Lou Gehrig's Disease

The ALS Association announced today its latest research awards that include funding commitments of $4 million to researchers in 31 laboratories in the United States, United Kingdom, Belgium, Germany and Canada. These awards are part of its Translational Research Advancing Therapies for ALS (TREAT ALS™) program, through which The Association funds a diverse portfolio of research to find treatments and a cure for Lou Gehrig's Disease.

9 Aug 2012

New report examines detrimental impact of building materials and products on asthma

Leading global interdisciplinary design firm Perkins+Will today released a new report examining the detrimental impact of building materials and products on asthma.

9 Aug 2012

Educational programs, increased physician collaboration can reduce inappropriate CCTA use

Appropriate use of testing is a hot topic in medicine as physicians and hospitals look for ways to improve quality while containing cost to achieve high-value care. This is especially true in the field of cardiology where the potential consequences of incorrect diagnosis have led to overuse of cardiovascular imaging with CT scanners, called coronary CT angiography.

9 Aug 2012

One third of all post-partum women exhibit some symptoms of PTSD

Post-Traumatic Stress Disorder (PTSD) develops in individuals who experience highly traumatizing situations such as terrorist attacks and car accidents, but symptoms can also come about after normal life events - including childbirth.

9 Aug 2012

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.

9 Aug 2012

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Teva Pharmaceutical Industries Ltd. and Active Biotech provided today an update on the clinical development program of once-daily oral laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS).

9 Aug 2012

VA agrees to move forward on CT screening for veterans at high risk for lung cancer

Today, Lung Cancer Alliance (LCA) announced that the Department of Veterans Affairs (VA) has agreed to move forward on CT screening for veterans at high risk for lung cancer. This was communicated to Laurie Fenton Ambrose, LCA President & CEO in written correspondence by VA Under Secretary for Health Dr. Robert A. Petzel.

9 Aug 2012

AbilTo, Aetna announce new program to help members with diabetes combat depression

The combination of depression and diabetes is common and potentially dangerous. People with depression can find it hard to make the lifestyle changes needed to manage diabetes. If not well managed, diabetes often leads to additional health issues, like heart, circulatory and kidney disease. Today, Aetna and AbilTo are announcing a new program to help members with diabetes combat depression and take control of their diabetes.

9 Aug 2012

Amgen announces decision to stop ganitumab Phase 3 trial in advanced pancreatic cancer

Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.

9 Aug 2012

Lightlake announces final data from naloxone nasal spray Phase II study on Binge Eating Disorder

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today compelling final data from a Phase II study of the Company's proprietary opioid antagonist naloxone nasal spray treatment for patients with Binge Eating Disorder (BED).

9 Aug 2012

FDA approves Codman’s MEDSTREAM Programmable Infusion System

Codman & Shurtleff, Inc. (Codman), the global neurological device company, has received U.S. Food and Drug Administration (FDA) approval through a PMA supplement for its MEDSTREAM Programmable Infusion System, an implantable infusion pump and catheter system used in the treatment of spasticity, a movement disorder often caused by stroke, cerebral palsy, multiple sclerosis or spinal cord injury.

9 Aug 2012

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Experimenting with human prostate cancer cells and mice, cancer imaging experts at Johns Hopkins say they have developed a method for finding and killing malignant cells while sparing healthy ones.

8 Aug 2012

Strategies that encourage lifestyle modifications could help manage hypertension

While many public health officials and healthcare providers view reducing sodium intake as the primary strategy to lower blood pressure, a 2010 expert Roundtable indicates that strategies that encourage lifestyle modifications could yield better results, concludes an article published today in the peer-reviewed journal Nutrition Today.

8 Aug 2012

Advanced Radiology to offer Amyvid for detection of AD

Advanced Radiology, a division of RadNet, Inc., a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of 237 fully-owned and operated outpatient imaging centers, announced it will be one of a small number of imaging centers in the U.S. to offer Amyvid, a radioactive tracer used in positron emission tomography – computed tomography (PET/CT) imaging that helps to detect the quantity of beta-amyloid plaque in patient's brains.

8 Aug 2012

Medical Condition News

First study to examine relationship of risky content in alcohol ads to youth exposure

Viewpoints: Dubious ad on Romney's role in cancer death; British health plan has problems of its own

MedPage Today, CollabRx sign license agreement for Oncology Next

The ALS Association announces new grants to support research on Lou Gehrig's Disease

New report examines detrimental impact of building materials and products on asthma

Educational programs, increased physician collaboration can reduce inappropriate CCTA use

One third of all post-partum women exhibit some symptoms of PTSD

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

VA agrees to move forward on CT screening for veterans at high risk for lung cancer

AbilTo, Aetna announce new program to help members with diabetes combat depression

Amgen announces decision to stop ganitumab Phase 3 trial in advanced pancreatic cancer

Lightlake announces final data from naloxone nasal spray Phase II study on Binge Eating Disorder

FDA approves Codman’s MEDSTREAM Programmable Infusion System

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Strategies that encourage lifestyle modifications could help manage hypertension

Advanced Radiology to offer Amyvid for detection of AD

Omeros completes enrollment in first of two OMS103HP Phase 3 meniscectomy trials

HCRI announces successful completion of randomization in DAPT Study

Patients in clinical trials of new targeted cancer therapies appear to have lower risk of side-effects

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News